Bayer AG

Fluor Completes Bayer’s First Global Cell Therapy Launch Facility

Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was celebrated on October 10, 2023, at the new facility with local officials, dignitaries, Bayer employees, and clients.

Bayer to Build New R&D Facility at German Site in Monheim

Bayer’ Crop Science division plans to invest €220 million in a new research and development (R&D) facility at its Monheim, Germany site. This is the company’s largest single investment in its crop protection business in Germany since the founding of the Monheim campus in 1979, Bayer said.

Bayer CEO Baumann Headed for early Exit?

CEO Werner Baumann may be headed for an early exit from Bayer, Bloomberg reports.

US Supreme Court Won’t Hear Bayer’s Roundup Petition

After months of anticipation, the US Supreme Court has deflated Bayer’s hopes that the court’s conservative majority would vote to hear its appeal to overturn a $25 million appeals court verdict in favor of Edwin Hardeman.

Bayer Wins Fourth Roundup Appeal as EPA Zooms in

Bayer has won its fourth consecutive appeal of a US court case previously decided in favor of a plaintiff who claimed that Monsanto’s glyphosate-based Roundup herbicide caused his non-Hodgkin lymphoma.

The Future Lies in the Genome

Bayer Sets Ambitious Targets for 2014

Bayer Sees Sharp Growth in Chinese Medical Market

Bayer Still Out To Buy, Not Sell, Vet Businesses

Bayer Healthcare Unit Says Eyes Takeovers In India

Bayer Remains On Lookout For Pharma Assets